|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 909.95 INR | +0.21% |
|
-3.71% | +2.94% |
| 06/01 | Fortis Healthcare says tax authority confirms demand of 59.8 million rupees | RE |
| 06/01 | Crisil Affirms Ratings on Fortis Healthcare's Bank Loan Facilities; Outlook Stable | MT |
Company Valuation: Fortis Healthcare Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,50,350 | 2,19,240 | 1,96,214 | 3,17,233 | 5,27,225 | 6,86,974 | - | - |
| Change | - | 45.82% | -10.5% | 61.68% | 66.19% | 30.3% | - | - |
| Enterprise Value (EV) 1 | 1,57,658 | 2,24,770 | 1,99,618 | 3,22,800 | 5,46,896 | 7,04,212 | 6,95,947 | 6,81,917 |
| Change | - | 42.57% | -11.19% | 61.71% | 69.42% | 28.77% | -1.17% | -2.02% |
| P/E ratio | -137x | 39.5x | 33.3x | 53x | 68.1x | 61.4x | 47x | 37.8x |
| PBR | 2.46x | 3.55x | 2.71x | 4.14x | 5.91x | 6.87x | 6.04x | 5.23x |
| PEG | - | -0x | 5.44x | 31.8x | 2.3x | 1.4x | 1.5x | 1.5x |
| Capitalization / Revenue | 3.73x | 3.83x | 3.12x | 4.6x | 6.77x | 7.46x | 6.35x | 5.58x |
| EV / Revenue | 3.91x | 3.93x | 3.17x | 4.68x | 7.03x | 7.64x | 6.43x | 5.54x |
| EV / EBITDA | 39x | 20.6x | 18.1x | 25.5x | 34.4x | 33x | 26.6x | 22.2x |
| EV / EBIT | 138x | 28.4x | 25.4x | 34.9x | 45.5x | 40.9x | 31.8x | 26x |
| EV / FCF | 57.5x | 30x | 53.2x | 205x | 94.8x | 104x | 49.9x | 39.9x |
| FCF Yield | 1.74% | 3.34% | 1.88% | 0.49% | 1.06% | 0.96% | 2% | 2.51% |
| Dividend per Share 2 | - | - | 1 | 1 | 1 | 1.36 | 1.564 | 1.751 |
| Rate of return | - | - | 0.38% | 0.24% | 0.14% | 0.15% | 0.17% | 0.19% |
| EPS 2 | -1.45 | 7.35 | 7.8 | 7.93 | 10.26 | 14.83 | 19.35 | 24.1 |
| Distribution rate | - | - | 12.8% | 12.6% | 9.75% | 9.17% | 8.08% | 7.27% |
| Net sales 1 | 40,301 | 57,176 | 62,976 | 68,929 | 77,828 | 92,116 | 1,08,199 | 1,23,034 |
| EBITDA 1 | 4,044 | 10,931 | 11,013 | 12,676 | 15,879 | 21,354 | 26,186 | 30,665 |
| EBIT 1 | 1,138 | 7,923 | 7,856 | 9,251 | 12,023 | 17,217 | 21,886 | 26,192 |
| Net income 1 | -1,098 | 5,551 | 5,887 | 6,011 | 7,742 | 11,224 | 14,581 | 18,106 |
| Net Debt 1 | 7,308 | 5,530 | 3,404 | 5,566 | 19,671 | 17,238 | 8,972 | -5,057 |
| Reference price 2 | 199.15 | 290.40 | 259.90 | 420.20 | 698.35 | 909.95 | 909.95 | 909.95 |
| Nbr of stocks (in thousands) | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | 7,54,958 | - | - |
| Announcement Date | 29/05/21 | 25/05/22 | 23/05/23 | 23/05/24 | 20/05/25 | - | - | - |
1INR in Million2INR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 61.23x | 7.63x | 32.91x | 0.15% | 759.03Cr | ||
| 39x | 3.4x | 15.2x | 1.19% | 1.86TCr | ||
| 29.81x | 4.6x | 16.13x | 1.42% | 1.58TCr | ||
| 55.95x | 4.38x | 29.8x | 0.3% | 1.16TCr | ||
| 18.64x | 2.11x | 10.02x | 0.72% | 1.01TCr | ||
| 30.23x | 2.34x | 19.95x | 0.14% | 1.02TCr | ||
| 17.04x | 2.52x | 10.19x | 4.33% | 887.79Cr | ||
| 14.14x | 1.25x | 7.9x | 1.23% | 765.28Cr | ||
| 26.39x | 0.81x | 6.72x | 2.42% | 550.69Cr | ||
| 39.98x | 5.23x | 25.09x | 0.27% | 424.51Cr | ||
| Average | 33.24x | 3.43x | 17.39x | 1.22% | 1TCr | |
| Weighted average by Cap. | 33.77x | 3.48x | 17.30x | 1.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- FORTIS Stock
- Valuation Fortis Healthcare Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















